Although gene therapy has slowed, Dr. Herzog has confidence in its eventual success. “I think it will be the choice of treatment in the future,” he says.
Dr. Miao was interested in helping patients with hemophilia overcome the two main treatment challenges—obtaining enough factor protein and dealing with inhibitors.
